Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (341-350 of 635) with videos related to

Pageof 64
Sort By:
NPJ Digital Medicine|June 28, 2022
Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)Ashish Sarraju, Clark Seninger, Vijaya Parameswaran, et al.
Journal of the American College of Cardiology|February 15, 2020
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery DiseaseAxel Haine, Sarah Kavanagh, Jeffrey S Berger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2015
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialPatrick S Parfrey, Tilman B Drüeke, Geoffrey A Block, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 24, 2017
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID TrialLars Norgren, Manesh R Patel, William R Hiatt, et al.
Clinical Cardiology|May 26, 2017
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantationEric Black-Maier, Sunghee Kim, Benjamin A Steinberg, et al.
Clinical Cardiology|January 1, 2016
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF RegistryLarry R Jackson, Sung Hee Kim, Jonathan P Piccini, et al.
International Journal of Cardiology|December 20, 2018
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trialJeremie Abtan, Gregory Ducrocq, Ph Gabriel Steg, et al.
The American Journal of Cardiology|September 20, 2018
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)Munveer Thind, DaJuanicia N Holmes, Marwan Badri, et al.
Journal of the American Society of Nephrology : JASN|December 16, 2014
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE TrialSharon M Moe, Safa Abdalla, Glenn M Chertow, et al.
Atherosclerosis|March 27, 2018
External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarctionBrent A Williams, Kevin M Chagin, Lori D Bash, et al.
Pageof 64

Showing results (341-350 of 635) with videos related to

Sort By:
Pageof 64
NPJ Digital Medicine|June 28, 2022
Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)Ashish Sarraju, Clark Seninger, Vijaya Parameswaran, et al.
Journal of the American College of Cardiology|February 15, 2020
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery DiseaseAxel Haine, Sarah Kavanagh, Jeffrey S Berger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2015
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialPatrick S Parfrey, Tilman B Drüeke, Geoffrey A Block, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 24, 2017
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID TrialLars Norgren, Manesh R Patel, William R Hiatt, et al.
Clinical Cardiology|May 26, 2017
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantationEric Black-Maier, Sunghee Kim, Benjamin A Steinberg, et al.
Clinical Cardiology|January 1, 2016
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF RegistryLarry R Jackson, Sung Hee Kim, Jonathan P Piccini, et al.
International Journal of Cardiology|December 20, 2018
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trialJeremie Abtan, Gregory Ducrocq, Ph Gabriel Steg, et al.
The American Journal of Cardiology|September 20, 2018
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)Munveer Thind, DaJuanicia N Holmes, Marwan Badri, et al.
Journal of the American Society of Nephrology : JASN|December 16, 2014
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE TrialSharon M Moe, Safa Abdalla, Glenn M Chertow, et al.
Atherosclerosis|March 27, 2018
External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarctionBrent A Williams, Kevin M Chagin, Lori D Bash, et al.
Pageof 64